New England Research & Management’s MaxLinear MXL Stock Holding History

New England Research & Management’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-11,374	Closed	-$359K	–	163
2023 Q2	$359K	Buy	+11,374	New	+$329K	0.21%	109
2023 Q1	–	Sell	-10,150	Closed	-$345K	–	167
2022 Q4	$345K	Buy	+10,150	New	+$344K	0.2%	127
2018 Q3	–	Sell	-29,550	Closed	-$461K	–	172
2018 Q2	$461K	Sell	29,550 -6,150	-17%	-$124K	0.3%	116
2018 Q1	$812K	Buy	35,700 +6,850	+24%	+$170K	0.54%	73
2017 Q4	$762K	Sell	28,850 -33,200	-54%	-$829K	0.55%	75
2017 Q3	$1.47M	Buy	62,050 +34,400	+124%	+$827K	1.08%	28
2017 Q2	$771K	Buy	+27,650	New	+$805K	0.57%	69
2017 Q1	–	Sell	-23,650	Closed	-$516K	–	181
2016 Q4	$516K	Buy	23,650 +11,073	+88%	+$229K	0.41%	83
2016 Q3	$255K	Sell	12,577 -10,823	-46%	-$213K	0.21%	142
2016 Q2	$421K	Buy	+23,400	New	+$434K	0.36%	95

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

New England Research & Management's MXL Position: Q3 2023 in Review

New England Research & Management sold out of MaxLinear (MXL) in Q3 2023, closing a stake of 11,374 shares — an estimated $359K sold.

New England Research & Management first reported a position in MXL in Q2 2016 and held it in 10 quarters. The position peaked at $1.47M in Q3 2017. 231 funds tracked by Wall St. Rank hold MXL as of Q3 2023.

New England Research & Management reported no remaining MaxLinear position as of Q3 2023 after selling out during the quarter.
New England Research & Management sold 11,374 MaxLinear shares in Q3 2023, an estimated $359K.
New England Research & Management first reported a position in MaxLinear in Q2 2016 and held it in 10 quarters.
New England Research & Management's MaxLinear position peaked at $1.47M in Q3 2017.
231 funds tracked by Wall St. Rank held MaxLinear as of Q3 2023.

Based on New England Research & Management's 13F filing for Q3 2023, filed 10 Oct 2023.